Novartis India Limited (BOM:500672)
India · Delayed Price · Currency is INR 980.55
+43.40 (4.63%)
At close: Mar 27, 2026
Novartis India Market Cap
Novartis India has a market cap or net worth of 24.21 billion as of March 27, 2026. Its market cap has increased by 23.46% in one year.
Market Cap
24.21B
Enterprise Value
18.08B
Revenue
3.48B
Ranking
n/a
PE Ratio
24.90
Stock Price
980.55
Market Cap Chart
Since April 14, 1999, Novartis India's market cap has increased from 12.59B to 24.21B, an increase of 92.37%. That is a compound annual growth rate of 2.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 25, 2026 | 23.14B | 20.30% |
| Dec 31, 2025 | 19.23B | -15.31% |
| Dec 31, 2024 | 22.71B | 18.95% |
| Dec 29, 2023 | 19.09B | 14.56% |
| Dec 30, 2022 | 16.67B | -12.94% |
| Dec 31, 2021 | 19.14B | 13.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gufic Biosciences | 29.26B |
| Bliss GVS Pharma | 23.66B |
| Unichem Laboratories | 21.05B |
| Hikal | 20.41B |
| Morepen Laboratories | 20.26B |
| Kwality Pharmaceuticals | 15.11B |
| Amrutanjan Health Care | 14.94B |
| Shukra Pharmaceuticals | 14.48B |